Difference in healthcare resource utilization and health-related quality of life between patients with major depressive disorder (MDD) and treatment-resistant depression (TRD) in a public hospital in Malaysia - a retrospective case-note review and cross-sectional survey

BackgroundMajor depressive disorder (MDD) is a growing global health concern, with its economic impact projected to reach USD 6.0 trillion by 2030. Treatment-resistant depression (TRD), characterized by non-responsiveness to initial treatments, adds a significant cost burden. In Malaysia, the Nation...

全面介绍

书目详细资料
发表在:EXPERT OPINION ON PHARMACOTHERAPY
Main Authors: Lee, Kenneth Kwing Chin; Mohamed, Nik Nur Eliza; Aziz, Salina Abdul; Nazri, Duratul'ain Mohamad; Malek, Akramul Zikri Abdul; Lim, Jing-Sheng; Wu, David Bin-Chia; Aftab, Raja Ahsan; Thanimalai, Subramaniam; Swaminathan, Meyyammai; Choon, June Wai Yee; Sellappans, Renukha
格式: 文件
语言:English
出版: TAYLOR & FRANCIS LTD 2025
主题:
在线阅读:https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001435581900001
author Lee
Kenneth Kwing Chin; Mohamed
Nik Nur Eliza; Aziz
Salina Abdul; Nazri
Duratul'ain Mohamad; Malek
Akramul Zikri Abdul; Lim
Jing-Sheng; Wu
David Bin-Chia; Aftab
Raja Ahsan; Thanimalai
Subramaniam; Swaminathan
Meyyammai; Choon
June Wai Yee; Sellappans
Renukha
spellingShingle Lee
Kenneth Kwing Chin; Mohamed
Nik Nur Eliza; Aziz
Salina Abdul; Nazri
Duratul'ain Mohamad; Malek
Akramul Zikri Abdul; Lim
Jing-Sheng; Wu
David Bin-Chia; Aftab
Raja Ahsan; Thanimalai
Subramaniam; Swaminathan
Meyyammai; Choon
June Wai Yee; Sellappans
Renukha
Difference in healthcare resource utilization and health-related quality of life between patients with major depressive disorder (MDD) and treatment-resistant depression (TRD) in a public hospital in Malaysia - a retrospective case-note review and cross-sectional survey
Pharmacology & Pharmacy
author_facet Lee
Kenneth Kwing Chin; Mohamed
Nik Nur Eliza; Aziz
Salina Abdul; Nazri
Duratul'ain Mohamad; Malek
Akramul Zikri Abdul; Lim
Jing-Sheng; Wu
David Bin-Chia; Aftab
Raja Ahsan; Thanimalai
Subramaniam; Swaminathan
Meyyammai; Choon
June Wai Yee; Sellappans
Renukha
author_sort Lee
spelling Lee, Kenneth Kwing Chin; Mohamed, Nik Nur Eliza; Aziz, Salina Abdul; Nazri, Duratul'ain Mohamad; Malek, Akramul Zikri Abdul; Lim, Jing-Sheng; Wu, David Bin-Chia; Aftab, Raja Ahsan; Thanimalai, Subramaniam; Swaminathan, Meyyammai; Choon, June Wai Yee; Sellappans, Renukha
Difference in healthcare resource utilization and health-related quality of life between patients with major depressive disorder (MDD) and treatment-resistant depression (TRD) in a public hospital in Malaysia - a retrospective case-note review and cross-sectional survey
EXPERT OPINION ON PHARMACOTHERAPY
English
Article
BackgroundMajor depressive disorder (MDD) is a growing global health concern, with its economic impact projected to reach USD 6.0 trillion by 2030. Treatment-resistant depression (TRD), characterized by non-responsiveness to initial treatments, adds a significant cost burden. In Malaysia, the National Health and Morbidity Survey 2023 reported a rising prevalence of depression in Malaysia, affecting approximately one million individuals. Research design and methodsA combined retrospective chart review and cross-sectional survey was conducted at the Psychiatry and Mental Health Clinic of Hospital Kuala Lumpur (HKL) over an 18-month period, examining 286 patients diagnosed with MDD or TRD. Data were analyzed from governmental and societal perspectives, including direct medical costs, indirect costs, and other resource utilization. ResultsTRD patients exhibited significantly higher health-care utilization, including a fivefold increase in the likelihood of attending more than 10 consultations (p = 0.035) and greater use of second-generation antipsychotics (p < 0.001). The average healthcare cost per TRD patient (RM1,845) was 55% higher than that of MDD patients (RM839). ConclusionEarly and effective management of MDD is essential to prevent progression to TRD, reducing healthcare resource utilization and costs. Adequate resource allocation for early intervention is critical to mitigate the economic impact of depression.
TAYLOR & FRANCIS LTD
1465-6566
1744-7666
2025
26
5
10.1080/14656566.2025.2472976
Pharmacology & Pharmacy
Green Submitted
WOS:001435581900001
https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001435581900001
title Difference in healthcare resource utilization and health-related quality of life between patients with major depressive disorder (MDD) and treatment-resistant depression (TRD) in a public hospital in Malaysia - a retrospective case-note review and cross-sectional survey
title_short Difference in healthcare resource utilization and health-related quality of life between patients with major depressive disorder (MDD) and treatment-resistant depression (TRD) in a public hospital in Malaysia - a retrospective case-note review and cross-sectional survey
title_full Difference in healthcare resource utilization and health-related quality of life between patients with major depressive disorder (MDD) and treatment-resistant depression (TRD) in a public hospital in Malaysia - a retrospective case-note review and cross-sectional survey
title_fullStr Difference in healthcare resource utilization and health-related quality of life between patients with major depressive disorder (MDD) and treatment-resistant depression (TRD) in a public hospital in Malaysia - a retrospective case-note review and cross-sectional survey
title_full_unstemmed Difference in healthcare resource utilization and health-related quality of life between patients with major depressive disorder (MDD) and treatment-resistant depression (TRD) in a public hospital in Malaysia - a retrospective case-note review and cross-sectional survey
title_sort Difference in healthcare resource utilization and health-related quality of life between patients with major depressive disorder (MDD) and treatment-resistant depression (TRD) in a public hospital in Malaysia - a retrospective case-note review and cross-sectional survey
container_title EXPERT OPINION ON PHARMACOTHERAPY
language English
format Article
description BackgroundMajor depressive disorder (MDD) is a growing global health concern, with its economic impact projected to reach USD 6.0 trillion by 2030. Treatment-resistant depression (TRD), characterized by non-responsiveness to initial treatments, adds a significant cost burden. In Malaysia, the National Health and Morbidity Survey 2023 reported a rising prevalence of depression in Malaysia, affecting approximately one million individuals. Research design and methodsA combined retrospective chart review and cross-sectional survey was conducted at the Psychiatry and Mental Health Clinic of Hospital Kuala Lumpur (HKL) over an 18-month period, examining 286 patients diagnosed with MDD or TRD. Data were analyzed from governmental and societal perspectives, including direct medical costs, indirect costs, and other resource utilization. ResultsTRD patients exhibited significantly higher health-care utilization, including a fivefold increase in the likelihood of attending more than 10 consultations (p = 0.035) and greater use of second-generation antipsychotics (p < 0.001). The average healthcare cost per TRD patient (RM1,845) was 55% higher than that of MDD patients (RM839). ConclusionEarly and effective management of MDD is essential to prevent progression to TRD, reducing healthcare resource utilization and costs. Adequate resource allocation for early intervention is critical to mitigate the economic impact of depression.
publisher TAYLOR & FRANCIS LTD
issn 1465-6566
1744-7666
publishDate 2025
container_volume 26
container_issue 5
doi_str_mv 10.1080/14656566.2025.2472976
topic Pharmacology & Pharmacy
topic_facet Pharmacology & Pharmacy
accesstype Green Submitted
id WOS:001435581900001
url https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001435581900001
record_format wos
collection Web of Science (WoS)
_version_ 1828987785778823168